Page results
-
Martin Jacobs joined UCLH as a non-executive director on 1 January 2020. He spent 20 years with PricewaterhouseCoopers (PwC) where he was a Partner within the Corporate Finance division.
-
UCLH and UCL researchers and engineers are using artificial intelligence (AI) to make brain surgery safer and more effective.
-
A team at UCLH and UCL have developed new methods to predict outcomes for pregnancies where there are issues with poor growth of the baby inside the womb.
-
A critical care nurse at The National Hospital for Neurology and Neurosurgery, Helen Burgess, has produced a short film to provide reassurance to relatives unable to visit their loved ones because of visitor restrictions during the Covid-19 pandemic.
-
Simon Porter joined UCLH as a non-executive director on 1 April 2020. He is a chartered accountant whose executive career at the London office of Ernst & Young ranged across audit, corporate finance and risk management.
-
The comprehensive review, co-authored by UCLH Director of Research Prof Bryan Williams, recommends approaches including mindfulness practices and reducing exposure to air polluion.
-
UCLH is to trial the COVID-19 vaccine developed by University of Oxford in healthy staff volunteers.
-
In his darkest moments, coronavirus patient Ertan Nazim feared he wouldn’t live to celebrate his 44th wedding anniversary.
-
Breathing aids developed by engineers at UCL, UCLH and Mercedes-AMG High Performance Powertrains have been delivered to 40 NHS hospitals across the country.
-
The huge impact the COVID-19 crisis is having on our patients and staff was the focus of a BBC News report broadcast tonight (Sunday).
File results
-
FOI/2023/0331 - Sexual assaults in hospitals from 2020 to 2023
-
FOI/2023/0292 - Spend on bank/ agency/ locum staff for junior doctor strike cover
-
FOI/2023/0299 - Trust Medical Examiner contact details
-
FOI/2023/0303 - Sexual harassment from patients towards staff in 2022
-
FOI/2023/0305 - Trust held non-pharmaceutical consignment stock holding
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2023/0338 - Individuals with a change to a gene called CACNA1C for 2021 and 2022
-
FOI/2023/0340 - NHS charging of overseas visitors